PATENT CLAIM ANALYSIS

Application Number: 15750818
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["514", "04400A"]

Abstract:
Provided herein are cell penetrating conjugates. The conjugates include a non-cell penetrating protein, a phosphorothioate nucleic acid, a first linker attaching the phosphorothioate nucleic acid to the non-cell penetrating protein and a second linker attaching the phosphorothioate nucleic acid to a therapeutic moiety (e.g., siRNA or small molecule), wherein the phosphorothioate nucleic acid enhances the intracellular delivery of the non-cell penetrating protein. The conjugates provided herein are, inter alia, useful for the treatment of cancer.

Claim (Index 59):
The method of  claim 57 , wherein said disease is selected from the group consisting of autoimmune disease, developmental disorder, inflammatory disease, metabolic disorder, cardiovascular disease, liver disease, intestinal disease, infectious disease, endocrine disease, neurological disorder, and cancer.

Metadata:
- Claim Count in Document: 43.0
- Percentile: 88.0
- Lexical Diversity: 1.95455
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14774512', '11233258', '12399241', '12288181', '11286920']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7786634843893346
- 35 USC 102 Novelty (BERT): 0.5243540788009151
- Combined Prediction Score: 0.7532325438304927
- Mean Citation Score: 276.32141
- Max Citation Score: 280.9147
- Similarity Product: 163.41977575859426

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test